Martine Rothblatt Insider Trading Activity
Martine Rothblatt has been net-selling over the last 12 months with 1 purchase and 1048 sales across 1 company.
UTHR is the most-traded position with 1049 trades. The largest single transaction was a sale of UTHR for $2.5M on Jul 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Martine Rothblatt. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | -5.7% | -2.2% | 51% | 989 |
| 90 days | -11.0% | +0.3% | 52% | 885 |
| 120 days | โ | -0.5% | 52% | 764 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersUTHR ยท UNITED THERAPEUTICS Corp
๐ Subscribe to see trade entries
Pro members see exactly when Martine Rothblatt bought and sold UTHR.
Upgrade to ProRecent Trades
Showing the 50 most recent of 1,049 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ฮ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Aug 24, 2026 | UTHR | Sell | 1,305 | $513.35 | $670K | โ0.4% | CEO | |
Aug 24, 2026 | UTHR | Sell | 3,056 | $511.63 | $1.6M | โ0.9% | CEO | |
Aug 24, 2026 | UTHR | Sell | 1,323 | $510.52 | $675K | โ0.4% | CEO | |
Aug 24, 2026 | UTHR | Sell | 224 | $509.41 | $114K | โ0.1% | CEO | |
Aug 24, 2026 | UTHR | Sell | 3,592 | $512.46 | $1.8M | โ1.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 235 | $525.42 | $123K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 625 | $524.35 | $328K | โ0.2% | CEO | |
Aug 21, 2026 | UTHR | Sell | 455 | $523.62 | $238K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 669 | $522.29 | $349K | โ0.2% | CEO | |
Aug 21, 2026 | UTHR | Sell | 371 | $521.28 | $193K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 440 | $520.03 | $229K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 837 | $519.09 | $434K | โ0.3% | CEO | |
Aug 21, 2026 | UTHR | Sell | 1,077 | $518.14 | $558K | โ0.3% | CEO | |
Aug 21, 2026 | UTHR | Sell | 773 | $517.07 | $400K | โ0.2% | CEO | |
Aug 21, 2026 | UTHR | Sell | 1,689 | $516.15 | $872K | โ0.5% | CEO | |
Aug 21, 2026 | UTHR | Sell | 624 | $515.26 | $322K | โ0.2% | CEO | |
Aug 21, 2026 | UTHR | Sell | 271 | $513.85 | $139K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 1,189 | $512.71 | $610K | โ0.4% | CEO | |
Aug 21, 2026 | UTHR | Sell | 200 | $527.71 | $106K | โ0.1% | CEO | |
Aug 21, 2026 | UTHR | Sell | 45 | $526.47 | $24K | โ0.0% | CEO | |
Aug 20, 2026 | UTHR | Sell | 2,357 | $520.46 | $1.2M | โ0.7% | CEO | |
Aug 20, 2026 | UTHR | Sell | 193 | $526.97 | $102K | โ0.1% | CEO | |
Aug 20, 2026 | UTHR | Sell | 240 | $525.10 | $126K | โ0.1% | CEO | |
Aug 20, 2026 | UTHR | Sell | 976 | $518.45 | $506K | โ0.3% | CEO | |
Aug 20, 2026 | UTHR | Sell | 800 | $523.26 | $419K | โ0.2% | CEO | |
Aug 20, 2026 | UTHR | Sell | 960 | $522.37 | $501K | โ0.3% | CEO | |
Aug 20, 2026 | UTHR | Sell | 2,470 | $521.39 | $1.3M | โ0.8% | CEO | |
Aug 20, 2026 | UTHR | Sell | 1,504 | $519.51 | $781K | โ0.5% | CEO | |
Aug 18, 2026 | UTHR | Sell | 231 | $510.47 | $118K | โ0.1% | CEO | |
Aug 18, 2026 | UTHR | Sell | 239 | $509.48 | $122K | โ0.1% | CEO | |
Aug 18, 2026 | UTHR | Sell | 441 | $518.65 | $229K | โ0.1% | CEO | |
Aug 18, 2026 | UTHR | Sell | 1,630 | $518.19 | $845K | โ0.5% | CEO | |
Aug 18, 2026 | UTHR | Sell | 873 | $517.09 | $451K | โ0.3% | CEO | |
Aug 18, 2026 | UTHR | Sell | 1,880 | $516.04 | $970K | โ0.6% | CEO | |
Aug 18, 2026 | UTHR | Sell | 2,333 | $514.99 | $1.2M | โ0.7% | CEO | |
Aug 18, 2026 | UTHR | Sell | 170 | $511.59 | $87K | โ0.1% | CEO | |
Aug 18, 2026 | UTHR | Sell | 1,264 | $514.18 | $650K | โ0.4% | CEO | |
Aug 18, 2026 | UTHR | Sell | 439 | $513.06 | $225K | โ0.1% | CEO | |
Aug 17, 2026 | UTHR | Sell | 213 | $501.06 | $107K | โ0.1% | CEO | |
Aug 17, 2026 | UTHR | Sell | 1,683 | $508.17 | $855K | โ0.5% | CEO | |
Aug 17, 2026 | UTHR | Sell | 3,298 | $507.43 | $1.7M | โ1.0% | CEO | |
Aug 17, 2026 | UTHR | Sell | 2,521 | $506.35 | $1.3M | โ0.8% | CEO | |
Aug 17, 2026 | UTHR | Sell | 1,238 | $505.36 | $626K | โ0.4% | CEO | |
Aug 17, 2026 | UTHR | Sell | 120 | $504.21 | $61K | โ0.0% | CEO | |
Aug 17, 2026 | UTHR | Sell | 427 | $502.18 | $214K | โ0.1% | CEO | |
Aug 6, 2026 | UTHR | Sell | 1,283 | $527.22 | $676K | โ0.4% | CEO | |
Aug 6, 2026 | UTHR | Sell | 80 | $512.50 | $41K | โ0.0% | CEO | |
Aug 6, 2026 | UTHR | Sell | 420 | $532.39 | $224K | โ0.1% | CEO | |
Aug 6, 2026 | UTHR | Sell | 400 | $531.42 | $213K | โ0.1% | CEO | |
Aug 6, 2026 | UTHR | Sell | 680 | $530.42 | $361K | โ0.2% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 1,049 | $524.1M |
Other insiders at UNITED THERAPEUTICS Corp
9 other tracked filers at UTHR.